Pain remains a leading cause of disability worldwide, and the opioid crisis has intensified demand for analgesics that preserve efficacy while reducing respiratory depression, tolerance, dependence, and misuse. Cebranopadol is an investigational spiroindole ligand that binds NOP, MOP, KOP, and DOP receptors with mixed...
M. Afighor, O. Adhekegba, C. E. Ezerioha et al.· Aminu Kano Academic Scholars...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.